- Home
- SEDG vs XERS Comparison
SEDG vs XERS Comparison
Compare SEDG & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEDG
- XERS
- Stock Information
- Founded
- SEDG 2006
- XERS 2005
- Country
- SEDG Israel
- XERS United States
- Employees
- SEDG N/A
- XERS N/A
- Industry
- SEDG Semiconductors
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- SEDG Technology
- XERS Health Care
- Exchange
- SEDG Nasdaq
- XERS Nasdaq
- Market Cap
- SEDG 714.4M
- XERS 628.7M
- IPO Year
- SEDG 2015
- XERS 2018
- Fundamental
- Price
- SEDG $19.84
- XERS $5.01
- Analyst Decision
- SEDG Hold
- XERS Strong Buy
- Analyst Count
- SEDG 24
- XERS 6
- Target Price
- SEDG $19.06
- XERS $6.25
- AVG Volume (30 Days)
- SEDG 4.6M
- XERS 2.2M
- Earning Date
- SEDG 05-06-2025
- XERS 05-08-2025
- Dividend Yield
- SEDG N/A
- XERS N/A
- EPS Growth
- SEDG N/A
- XERS N/A
- EPS
- SEDG N/A
- XERS N/A
- Revenue
- SEDG $916,537,000.00
- XERS $222,551,000.00
- Revenue This Year
- SEDG $19.14
- XERS $31.75
- Revenue Next Year
- SEDG $33.33
- XERS $21.09
- P/E Ratio
- SEDG N/A
- XERS N/A
- Revenue Growth
- SEDG N/A
- XERS 29.88
- 52 Week Low
- SEDG $10.24
- XERS $1.72
- 52 Week High
- SEDG $56.52
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- SEDG 72.74
- XERS 59.63
- Support Level
- SEDG $12.47
- XERS $4.26
- Resistance Level
- SEDG $13.44
- XERS $5.28
- Average True Range (ATR)
- SEDG 1.24
- XERS 0.28
- MACD
- SEDG 0.85
- XERS 0.09
- Stochastic Oscillator
- SEDG 96.99
- XERS 78.91
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).